Department of Physical Therapy Faculty Articles

Comparing Cellular Uptake and Cytotoxicity of Targeted Drug Carriers in Cancer Cell Lines With Different Drug Resistance Mechanisms.

Publication Title

Nanomedicine

ISSN

1549-9642

Publication Date

6-2011

Keywords

Antibodies, Cell Line, Doxorubicin, Drug Carriers, Neoplasm, Endocytosis, Intracellular Space, Kinetics, Confocal, Nanoparticles, Particle Size, Scattering, Radiation, Static Electricity, Subcellular Fractions

Abstract

The purpose of this study was to compare the cellular uptake and cytotoxicity of targeted and nontargeted doxorubicin (DOX)-loaded poly (d,l-lactide co-glycolide) (PLGA) nanoparticle (NP) drug delivery systems in drug-resistant ovarian (SKOV-3) and uterine (MES-SA/Dx5) cancer cell lines. The cellular uptakes of DOX from nonconjugated DOX-loaded NPs (DNPs) and from HER-2 antibody-conjugated DOX-loaded NPs (ADNPs) in MES-SA/Dx5 cancer cells were higher compared to free DOX. Results also showed higher uptake of DOX from ADNPs in SKOV-3 cells compared with both free DOX and DNPs treatment. Cytotoxicity results at 10 μM extracellular DOX concentration were consistent with the cellular uptake results. Our study concludes that cellular uptake and cytotoxicity of DOX can be improved in MES-SA/Dx5 cells by loading DOX into PLGA NPs. DNPs targeted to membrane receptors may enhance cellular uptake and cytotoxicity in SKOV-3 cells. FROM THE CLINICAL EDITOR: The authors of this study compare the cellular uptake and cytotoxicity of targeted and nontargeted doxorubicin loaded PLGA nanoparticle delivery systems in drug-resistant ovarian and uterine cancer cell lines, concluding that cellular uptake and cytotoxicity of doxorubicin can be improved by the proposed methods.

DOI

10.1016/j.nano.2010.11.004

Volume

7

Issue

3

First Page

324

Last Page

332

Disciplines

Medicine and Health Sciences

This document is currently not available here.

Find in your library

Share

COinS